NEW YORK (GenomeWeb) – Thermo Fisher Scientific said after the close of the market on Thursday it has priced an offering of €500 million ($544 million) aggregate principal amount of 2.150 percent senior notes. 

The notes, due in 2022, were priced at 99.788 percent of the principal amount. The issuance of the notes is expected to close on or about July 21. Net proceeds will go toward general corporate purposes, Thermo Fisher said. 

The joint book-running managers on the offering are BNP Paribas and HSBC Bank. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.